Monte Rosa Therapeutics, Inc. - Common Stock, $0.0001 par value per share (GLUE)

CUSIP: 61225M102

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
65,015,017
Total 13F shares
60,988,332
Share change
+11,215,580
Total reported value
$423,262,031
Put/Call ratio
5.8%
Price per share
$6.94
Number of holders
104
Value change
+$79,110,231
Number of buys
64
Number of sells
28

Quarterly Holders Quick Answers

What is CUSIP 61225M102?
CUSIP 61225M102 identifies GLUE - Monte Rosa Therapeutics, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Monte Rosa Therapeutics, Inc. - Common Stock, $0.0001 par value per share (GLUE) as of Q4 2024

As of 31 Dec 2024, Monte Rosa Therapeutics, Inc. - Common Stock, $0.0001 par value per share (GLUE) was held by 104 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 60,988,332 shares. The largest 10 holders included NEA Management Company, LLC, PRICE T ROWE ASSOCIATES INC /MD/, Versant Venture Management, LLC, FMR LLC, BAKER BROS. ADVISORS LP, Avoro Capital Advisors LLC, BlackRock, Inc., VANGUARD GROUP INC, BVF INC/IL, and MORGAN STANLEY. This page lists 104 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.